BDTB Bodhi Tree Biotechnology Inc.
Fundamentals / CIK 0002041531 / USDBodhi Tree Biotechnology Inc. reported $37K in revenue and a net loss of $116K for the trailing twelve months ended June 30, 2026, with a -310.2% operating margin.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open BDTB in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue TTM$37K Jun 30, 2026
-
Operating Income TTM-$115K -310.2% margin
-
Net Income TTM-$116K -313.6% net margin
-
Diluted EPS TTM-$0.00 Split-adjusted
-
Free Cash Flow TTM-- Operating CF less CapEx
-
Cash & ST Investments Jun 30, 2026$4.0K Total debt: --
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Sep 30 |
|---|---|
| Revenue | $17K |
| Operating Income | -$148K |
| Income Before Tax | -$148K |
| Income Tax Expense | $2.0K |
| Net Income | -$150K |
| Basic EPS | -$0.01 |
| Diluted EPS | -$0.01 |
| Basic Shares Outstanding | 25.4M |
| Diluted Shares Outstanding | 25.4M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $10K | $15K | $0 | $12K | $0 | $0 | $5.0K | -- |
| Operating Income | -$23K | -$28K | -$53K | -$11K | -$20K | -$52K | -$65K | -$72K |
| Income Before Tax | -$23K | -$28K | -$53K | -$11K | -$20K | -$52K | -$65K | -- |
| Income Tax Expense | -- | $1.3K | -- | -- | $800 | $1.2K | -- | -- |
| Net Income | -$23K | -$29K | -$53K | -$11K | -$21K | -$53K | -$65K | -$72K |
| Basic EPS | $0.00 | $0.00 | -$0.01 | -- | $0.00 | $0.00 | $0.00 | -- |
| Diluted EPS | $0.00 | $0.00 | -$0.01 | -- | $0.00 | $0.00 | $0.00 | -- |
| Basic Shares Outstanding | 25.4M | 25.4M | 25.4M | -- | 25.4M | 25.4M | 25.4M | -- |
| Diluted Shares Outstanding | 25.4M | 25.4M | 25.4M | -- | 25.4M | 25.4M | 25.4M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Sep 30 | Sep 30 |
|---|---|---|
| Cash & Cash Equivalents | $109K | $260K |
| Cash & Short-Term Investments | $109K | $260K |
| Total Assets | $119K | $269K |
| Total Current Liabilities | -- | $500 |
| Total Non-Current Liabilities | -- | $0 |
| Total Liabilities | $0 | $500 |
| Common Stock | $2.5K | $2.5K |
| Retained Earnings | -$212K | -$62K |
| Total Stockholders' Equity | $119K | $269K |
| Total Equity | $119K | $269K |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $4.0K | $23K | $47K | $109K | $120K | $144K | $260K |
| Cash & Short-Term Investments | $4.0K | $23K | $47K | $109K | $120K | $144K | $260K |
| Total Assets | $18K | $41K | $70K | $119K | $130K | $151K | $269K |
| Total Current Liabilities | $4.5K | $3.5K | $3.5K | -- | -- | -- | $500 |
| Total Non-Current Liabilities | $0 | $0 | $0 | -- | -- | -- | $0 |
| Total Liabilities | $4.5K | $3.5K | $3.5K | $0 | $0 | $0 | $500 |
| Common Stock | $2.5K | $2.5K | $2.5K | $2.5K | $2.5K | $2.5K | $2.5K |
| Retained Earnings | -$317K | -$294K | -$265K | -$212K | -$201K | -$180K | -$62K |
| Total Stockholders' Equity | $14K | $37K | $66K | $119K | $130K | $151K | $269K |
| Total Equity | $14K | $37K | $66K | $119K | $130K | $151K | $269K |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Sep 30 |
|---|---|
| Net Income | -$150K |
| Operating Cash Flow | -$150K |
| Net Change in Cash | -$150K |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$23K | -$29K | -$53K | -$11K | -$21K | -$53K | -$65K | -$72K |
| Operating Cash Flow | -$19K | -$25K | -$62K | -$10K | -$25K | -$50K | -$65K | -$91K |
| Financing Cash Flow | -- | -- | -- | -- | -- | -- | -- | $281K |
| Net Change in Cash | -$19K | -$25K | -$62K | -$10K | -$25K | -$50K | -$65K | $190K |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Sep 30 |
|---|---|
| Operating Margin | -868.3% |
| Net Profit Margin | -880.4% |
| Return on Equity (ROE) | -125.6% |
| Return on Assets (ROA) | -125.6% |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -310.2% | -413.1% | -1131.6% | -868.3% | -- | -- | -- | -- |
| Net Profit Margin | -313.6% | -420.8% | -1148.6% | -880.4% | -- | -- | -- | -- |
| Return on Equity (ROE) | -839.4% | -306.9% | -208.2% | -125.6% | -162.1% | -119.5% | -- | -- |
| Return on Assets (ROA) | -633.2% | -280.4% | -197.7% | -125.6% | -162.1% | -119.5% | -- | -- |
| Quick Ratio | 0.89x | 6.50x | 13.53x | -- | -- | -- | -- | 519.14x |
| Revenue Growth (YoY) | -- | -- | -100.0% | -- | -100.0% | -- | -- | -- |
| Operating Income Growth (YoY) | -- | -- | -- | -- | -305.3% | -- | -- | -- |
| Net Income Growth (YoY) | -- | -- | -- | -- | -313.5% | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -- | -227.1% | -13154.2% | -- | -- |